Coherus Oncology
CHRS
CHRS
109 hedge funds and large institutions have $793M invested in Coherus Oncology in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
11% less funds holding
Funds holding: 122 → 109 (-13)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
109
Holding in Top 10
1
Calls
$6.08M
Puts
$4.85M
Top Buyers
| 1 | +$60.1M | |
| 2 | +$31.7M | |
| 3 | +$23.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22M |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$17M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$3.25M | |
| 3 | -$2.11M | |
| 4 |
Morgan Stanley
New York
|
-$1.82M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$1.69M |